We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNET
2626
DELISTED
RigNet, Inc.
RNET
| $249K | ﹤0.01% |
19,697
+6,070
| +45% | +$101K |
|
2627
Diageo
DEO
$51.5B
| $248K | ﹤0.01% |
1,747
+25
| +1% | +$3.52K |
|
2628
Nathan's Famous
NATH
$404M
| $248K | ﹤0.01% |
3,730
+1,249
| +50% | +$92.1K |
|
|
ABB
2629
DELISTED
ABB Ltd
ABB
| $248K | ﹤0.01% |
13,036
+379
| +3% | +$7.67K |
|
|
AMBR
2630
DELISTED
Amber Road Inc
AMBR
| $248K | ﹤0.01% |
30,131
+10,191
| +51% | +$90.2K |
|
2631
Amalgamated Financial
AMAL
$1.5B
| $247K | ﹤0.01% |
+12,676
| New | +$249K |
|
|
LAND
2632
Gladstone Land Corp
LAND
$361M
| $247K | ﹤0.01% |
21,490
+7,071
| +49% | +$88.5K |
|
|
IHC
2633
DELISTED
Independence Holding Company
IHC
| $247K | ﹤0.01% |
7,021
+343
| +5% | +$12.7K |
|
2634
Union Bankshares
UNB
$108M
| $246K | ﹤0.01% |
+5,147
| New | +$242K |
|
|
ADVM
2635
DELISTED
Adverum Biotechnologies
ADVM
| $245K | ﹤0.01% |
7,790
+2,308
| +42% | +$93.9K |
|
2636
Consolidated Water Co
CWCO
$482M
| $245K | ﹤0.01% |
21,025
+6,424
| +44% | +$80.5K |
|
|
SBOW
2637
DELISTED
SilverBow Resources, Inc.
SBOW
| $245K | ﹤0.01% |
+10,357
| New | +$267K |
|
|
CPRX
2638
DELISTED
Catalyst Pharmaceutical
CPRX
| $243K | ﹤0.01% |
126,699
+42,199
| +50% | +$121K |
|
|
BRS
2639
DELISTED
Bristow Group, Inc.
BRS
| $243K | ﹤0.01% |
100,080
+17,866
| +22% | +$135K |
|
2640
Rocky Brands
RCKY
$373M
| $242K | ﹤0.01% |
+9,302
| New | +$240K |
|
|
LBC
2641
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $242K | ﹤0.01% |
26,842
+9,812
| +58% | +$95.7K |
|
2642
Bankwell Financial Group
BWFG
$533M
| $241K | ﹤0.01% |
+8,404
| New | +$247K |
|
|
DCPH
2643
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $241K | ﹤0.01% |
11,466
+4,000
| +54% | +$98.3K |
|
|
BREW
2644
DELISTED
Craft Brew Alliance, Inc.
BREW
| $241K | ﹤0.01% |
16,864
+5,522
| +49% | +$90.9K |
|
|
PBPB
2645
DELISTED
Potbelly
PBPB
| $240K | ﹤0.01% |
29,858
+9,918
| +50% | +$106K |
|
|
IIN
2646
DELISTED
IntriCon Corporation
IIN
| $240K | ﹤0.01% |
9,104
+3,375
| +59% | +$128K |
|
|
SPA
2647
DELISTED
Sparton
SPA
| $240K | ﹤0.01% |
+13,214
| New | +$194K |
|
|
GCAP
2648
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $239K | ﹤0.01% |
38,821
+10,950
| +39% | +$79.5K |
|
|
FPI
2649
Farmland Partners
FPI
$436M
| $238K | ﹤0.01% |
52,320
+16,298
| +45% | +$102K |
|
2650
KVH Industries
KVHI
$162M
| $237K | ﹤0.01% |
22,987
+7,022
| +44% | +$80.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.